Lexicon Pharmaceuticals Inc logo

Lexicon Pharmaceuticals Inc

$ 2.55 +0.13 (+5.37%) 10:08 PM EST
On watch
P/E:
At Loss
P/B:
5.39
Market Cap:
$ 481.25M
Enterprise V:
$ 444.70M
Volume:
502.00K
Avg Vol (2M):
1.09M
Also Trade In:
Volume:
502.00K
Market Cap $:
481.25M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.09M
Enterprise Value $:
444.70M
PB Ratio:
5.39
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of pharmaceutical products for the treatment of human disease. Some of its drugs candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
Name Current Vs Industry Vs History
Cash-To-Debt 2.44
Equity-to-Asset 0.63
Debt-to-Equity 0.36
Debt-to-EBITDA -0.27
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -14.48
Distress
Grey
Safe
Beneish M-Score -3.17
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 60.67
9-Day RSI 48.94
14-Day RSI 46.73
6-1 Month Momentum % 34.13
12-1 Month Momentum % -45.51

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.85
Quick Ratio 3.85
Cash Ratio 3.68
Days Sales Outstanding 178.82

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12

Financials (Next Earnings Date:2022-11-03 Est.)

LXRX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:LXRX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.109
EPS (TTM) ($) -0.65
Beta 1.46
Volatility % 59.01
14-Day RSI 46.73
14-Day ATR ($) 0.158563
20-Day SMA ($) 2.617
12-1 Month Momentum % -45.51
52-Week Range ($) 1.31 - 6.3299
Shares Outstanding (Mil) 188.73

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Lexicon Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Lexicon Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.